Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: The PARTNER II Trial: Placement of AoRTicTraNscathetER Valves Trial The Safety and Effectiveness of the SAPIEN XT™ Transcatheter Heart Valve with NovaFlex and Ascendra 2 delivery systems (Transfemoral and Transapical) in Intermediate Risk for Aortic Valve

 


The PARTNER II Trial: Placement of AoRTicTraNscathetER Valves Trial The Safety and Effectiveness of the SAPIEN XT™ Transcatheter Heart Valve with NovaFlex and Ascendra 2 delivery systems (Transfemoral and Transapical) in Intermediate Risk for Aortic Valve


Trial Focus

Trial Focus

Heart & Circulation

Objective

        
The purpose of this investigational trial is to establish the safety and effectiveness of a new device and delivery systems in patients with aortic stenosis (narrowing of the aortic valve resulting in obstructed blood flow).

IRB Protocol #

12-0660

Trial Status

Accepting Participants

Contact

Heather Maurer at 303-724-6473

Eligibility and Other Participant Information


Adults with severe, symptomatic aortic stenosis and would benefit from valve implantation may be eligible for the trial. In addition, adults with stenosed or insufficient bioprosthetic valve in any position may be eligible for the registry. Please contact the study coordinator for specific inclusion and exclusion criteria.